- With this incorporation, the company now has a total of 23 reproductive genetics laboratories worldwide
- Canada carries out 33,000 IVF cycles per year
On December 14th, 2020 Igenomix announced the acquisition of the Toronto-based laboratory Access Genomics, owned by Persistence Capital Partners. This reinforces Igenomix position in a growing country in the field of reproductive medicine, where it can better serve the needs of its clients in the Toronto area.
Igenomix, which already had a presence in Canada through its representative office, has established itself as a leading laboratory in Toronto. This acquisition of Access Genomics laboratory will also enable the biotechnology company to increase its portfolio of clients to a total of 36 reproduction clinics and offer quality service to its clientele.
“Expanding Igenomix in Canada is a natural process in the reproduction market. We are a leading company in the field of genetic diagnosis at an international level and increasing our laboratory network in a country which carries out 33,000 IVF cycles per year is a necessary and exciting step,” explains David Jiménez, the company CEO.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.